Nu-Med

Elblag, Poland Founded: 2017 • Age: 9 yrs Acquired By Affidea
Standalone general clinic

About Nu-Med

Nu-Med is a Healthcare company based in Elblag (Poland) founded in 2017, and was acquired by Affidea in August 2024. Standalone general clinic. Nu-Med offers products and services including Radiotherapy and Diagnostic Imaging. Its focus areas include Clinics and General Clinics. Its legal entity is NU-MED Grupa S.A.

Company details

Nu-Med was established in 2017 as a standalone general clinic based in Elblag, Poland. Primary healthcare services, including consultations and treatments, are offered to local patients. Operations are conducted independently, without integration into larger medical networks. The clinic focuses on routine medical care within the healthcare sector, serving the regional community through its domain nu-med.pl. Standard diagnostic and therapeutic procedures are handled on-site.

  • Headquarters Elblag, Poland
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website nu-med.pl
  • Social LinkedIn Facebook
  • Acquired by Affidea (Aug 2024)
  • Legal Name Nu-Med Grupa S.A.
Key Metrics
  • Latest Funding Round
    $45.95M (USD), Debt – Conventional

    Oct 2023

  • Investors
    mBank

    & 1 more

  • Acquired by
    Affidea

    (Aug 2024)

Products & Services of Nu-Med

Nu-Med offers a comprehensive portfolio of products and services, including Radiotherapy and Diagnostic Imaging.

Radiotherapy
Cancer Treatment

Radiotherapy is employed as a method for treating malignant tumors and certain non-oncological conditions.

Diagnostic Imaging
Diagnostics

Diagnostic imaging is utilized to perform scans like CT and MRI for the detection and monitoring of diseases.

Funding Insights of Nu-Med

  • Total Rounds 1
  • Last Round Debt – Conventional β€” $45.95M
  • First Round $45.95M

    (Oct 2023)

  • Investors Count 1

All 1 funding rounds of Nu-Med with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2023$45.95MDebt – Conventional––
Valuation history

2 investors in total: 2 institutional.

Investors in Nu-Med

Nu-Med has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include mBank and Affidea.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Commercial banking services are provided in Poland.
1986mbank.plLodz, Poland
Diagnostic imaging and cancer treatment services are delivered pan-European.
1995affidea.comLisbon, Portugal
Premium access

Investor details for Nu-Med

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Nu-Med

3 dated milestones of Nu-Med across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Nu-Med is founded.
  2. Funding First funding round of $46.0M.
  3. Exit Acquired by Affidea.

Web traffic of Nu-Med

The website of Nu-Med (nu-med.pl) receives about 3.4K visits a month.

  • Monthly visits
    3.4K

    ▼ 21.6% vs previous month

Similar websites

Websites whose visitors overlap most with Nu-Med. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
wszplock.pl
wszplock.pl
100%
#2,857,914–
centrum-radioterapii.pl
centrum-radioterapii.pl
98%
#12,260,754–
lukasz.med.pl
lukasz.med.pl
91%
#936,365–
onkomapa.pl
onkomapa.pl
83%
#888,052–
qdiagnostica.com
qdiagnostica.com
76%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 14 similar websites and full traffic analytics for Nu-Med

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 14 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Nu-Med

Nu-Med was founded in 2017 and raised its 1st funding round 6 years after it was founded.

Nu-Med is headquartered in Elblag, Poland. It is registered at Elblag, Warmian-masurian Voivodeship, Poland.

Nu-Med was established in 2017 as a standalone general clinic based in Elblag, Poland. Primary healthcare services, including consultations and treatments, are offered to local patients. Operations are conducted independently, without integration into larger medical networks. The clinic focuses on routine medical care within the healthcare sector, serving the regional community through its domain nu-med.pl. Standard diagnostic and therapeutic procedures are handled on-site.

Nu-Med offers Radiotherapy and Diagnostic Imaging.

Nu-Med has 2 investors. Key investors include mBank, and Affidea.

Nu-Med operates through Nu-Med Grupa S.A..

Yes. Nu-Med was acquired by Affidea in August 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available